Phase 2b data show RAD101 amino acid PET hits 90% concordance, helping distinguish brain metastasis recurrence from ...
Algernon Health Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), is pleased to introduce ...
Algernon Health (CSE:AGN, OTCQB:AGNPF, FRA:AGW0) on Wednesday announced “NovaScan Neuroimaging Clinics” as the new brand name ...
Algernon Health Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), is pleased to announce that ...
InvestorsHub on MSN
Radiopharm reports 90% concordance in interim results for RAD 101 brain metastases trial
Radiopharm Theranostics (NASDAQ:RADX) announced interim findings from its Phase 2b clinical trial evaluating RAD 101, an ...
Add Yahoo as a preferred source to see more of our stories on Google. Biologically speaking, there is no organ as vital or complex as the brain. And yet, the brain still remains somewhat a of a ...
Vietnam Investment Review on MSN
Telix resubmits brain cancer imaging drug application to FDA
MELBOURNE, Australia and INDIANAPOLIS, March 16, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, ...
With a simple brain scan, providers can now better detect and monitor Alzheimer’s disease. Dr. Tracy Vargas, a neurologist at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results